GeneOne Life Science Inc Cash Flow-to-Debt Ratio
GeneOne Life Science Inc cash flow-to-debt ratio. GeneOne Life Science Inc (011000) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of ₩-2.84 Billion could theoretically repay 0% of its total liabilities (₩80.13 Billion) in one year. Check earnings quality score of GeneOne Life Science Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GeneOne Life Science Inc (2013–2025)
Cash flow-to-debt ratio of GeneOne Life Science Inc from 2013 to 2025. Historical debt coverage capacity for GeneOne Life Science Inc across 13 annual periods. Check GeneOne Life Science Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
GeneOne Life Science Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
GeneOne Life Science Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for GeneOne Life Science Inc. For the full cash flow conversion analysis, see GeneOne Life Science Inc (011000) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.21x | ₩-16.54 Billion | ₩78.31 Billion | ▲ +13.5% |
| 2024 | -0.24x | ₩-16.06 Billion | ₩65.73 Billion | ▲ +55.6% |
| 2023 | -0.55x | ₩-21.74 Billion | ₩39.52 Billion | ▲ +5.5% |
| 2022 | -0.58x | ₩-24.11 Billion | ₩41.40 Billion | ▼ -429.0% |
| 2021 | -0.11x | ₩-4.85 Billion | ₩44.04 Billion | ▲ +73.7% |
| 2020 | -0.42x | ₩-15.92 Billion | ₩38.06 Billion | ▼ -792.0% |
| 2019 | -0.05x | ₩-1.27 Billion | ₩27.09 Billion | ▲ +87.2% |
| 2018 | -0.37x | ₩-7.27 Billion | ₩19.89 Billion | ▲ +17.7% |
| 2017 | -0.44x | ₩-4.04 Billion | ₩9.09 Billion | ▼ -6.9% |
| 2016 | -0.42x | ₩-12.39 Billion | ₩29.81 Billion | ▼ -540.5% |
| 2015 | 0.09x | ₩778.50 Million | ₩8.25 Billion | ▲ +113.7% |
| 2014 | -0.69x | ₩-4.16 Billion | ₩6.03 Billion | ▼ -138.1% |
| 2013 | -0.29x | ₩-2.35 Billion | ₩8.11 Billion | — |